p53-Independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages

Cancer Letters

Volumn 129, Issue 2, 1998, Pages 191-197

  Mei, Jay J M ^a   Hursting, Stephen D ^a,b   Perkins, Susan N ^a   Phang, James M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Calorie restriction; Cancer prevention; DHEA; Nitric oxide; p53

Indexed keywords

DYDROGESTERONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P53; STEROID;

ANIMAL CELL; ARTICLE; CALORIC RESTRICTION; CANCER PREVENTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANDROSTENES; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; DOWN-REGULATION; ENERGY INTAKE; GENES, P53; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0032547016     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00102-5     Document Type: Article

References (21)

1. Hursting S.D., Perkins S.N., Phang J.M. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;7036-7040.
2. Hursting S.D., Perkins S.N., Haines D.C., Ward J.M., Phang J.M. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res. 55:1995;3949-3953.
3. Perkins S.N., Hursting S.D., Haines D.C., James S.J., Miller B.J., Phang J.M. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16α-fluoro-5-androsten-17-one. Carcinogenesis. 18:1997;989-994.
4. Schwartz A.G., Pashko L.L. Role of adrenocortical steroids in mediating cancer-preventive and age-retarding effects of food restriction in laboratory rodents. J. Gerontol. 49:1994;B37-B41.
5. Roecker E.B., Kemnitz J.W., Ershler W.B., Weindruch R. Reduced immune responses in rhesus monkeys subjected to dietary restriction. J. Gerontol. 51:1996;B276-B279.
6. Wachsman J.T. The beneficial effects of dietary restriction: reduced oxidative damage and enhanced apoptosis. Mutat. Res. 350:1996;25-34.
7. MacMicking J., Xie Q., Nathan C. Nitric oxide and macrophages. Annu. Rev. Immunol. 15:1997;323-350.
8. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 301:1994;253-264.
9. Brouet I., Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206:1995;533-540.
10. Burkart V., Gross-Eick A., Bellmann K., Radons J., Kolb H. Suppression of nitric oxide toxicity in islet cells by alpha-tocopherol. FEBS Lett. 364:1995;259-263.
11. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57:1997;3300-3304.
12. Forrester K., Ambs S., Lupold S.E., Kapust R.B., Spillare E.A., Weinberg W.C., Felley-Bosco E., Wang X.W., Geller D.A., Tzeng E., Billiar T.R., Harris C.C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA. 93:1996;2442-2447.
13. Schmidt H.H.H.W., Zernikow B., Baeblich S., Bohme E. Basal and stimulated formation and release of L-arginine-derived nitrogen oxide from cultured endothelial cells. J. Pharmacol. Exp. Ther. 254:1990;591-597.
14. Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 339:1995;73-89.
15. Laychock S.G., Bauer A.L. Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1β effects in pancreatic islets. Endocrinology. 137:1996;3375-3385.
16. Kleiner H., Euchenhofer C., Ihrig-Biedert I., Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Mol. Pharmacol. 49:1996;15-21.
17. Rao M.S., Subbarao V., Yeldandi A.V., Reddy J.K. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res. 52:1992;2977-2979.
18. Youngman L.D., Park J.Y., Ames B.N. Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc. Natl. Acad. Sci. USA. 89:1992;9112-9116.
19. W. Dong, M.K. Selgrade, M.I. Gilmour, R.W. Lang, P. Park, M.I. Luster, F.W. Kari, Altered alveolar macrophage function in calorie-restricted rats, Am. J. Res. Cell Mol. Biol. (1998), in press.
20. Donehower L.A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7:1996;269-278.
21. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.